×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Shopping
Maps
Videos
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Motif FoodWorks CEO departs amid new round of layoffs
AgFunderNews
Motif FoodWorks CEO Dr. Mike Leonard has left the Boston-based foodtech firm, which has just engaged in a new round of layoffs.
5 months ago
Motif Neurotech Raises $18.75M for Implantable Device for Treatment-Resistant Depression
HIT Consultant
What You Should Know: – Motif Neurotech, a pioneer in minimally-invasive bioelectronics for mental health, announced today an impressive...
3 months ago
Motif Bio: Lessons from a failed pharma
Investors' Chronicle
Motif Bio: Lessons from a failed pharma · Motif Bio failed to get its novel antibiotic approved in the US leading to the eventual collapse of...
34 months ago
Motif FoodWorks Adds Bioprocessing Services to their Menu
PR Newswire
Motif first broke ground on their new facilities in late 2021 with renovations to the office space and R&D facilities being completed in the...
14 months ago
Recon: FDA Rejects Motif Bio Antibiotic; AstraZeneca Drops MedImmune Name in R&D Restructuring
Regulatory Affairs Professionals Society | RAPS
Welcome to Regulatory Reconnaissance, your daily regulatory news and intelligence briefing.
62 months ago
Motif Bio files for a $40 million IPO
renaissancecapital.com
Motif Bio, which is developing novel antibiotics effective against multi-drug resistant bacteria, filed on Wednesday with the SEC to raise...
93 months ago
Brief: Impossible Foods goes after Ginkgo Bioworks in amended lawsuit over heme proteins in alt meat
AgFunderNews
Impossible Foods has added Ginkgo Bioworks as a defendant in its patent infringement lawsuit against foodtech rival Motif Foodworks over the...
9 months ago
Motif Bio : The home plate beckons | AIM:MTFB
Proactive financial news
Motif Bio Plc (LON:MTFB) on Wednesday came a step closer to crossing home plate with its lead product, a next-generation antibiotic called...
79 months ago
Motif Neurotech Raises $18.75 Million in Series A Financing to Advance Implantable Device for Treatment-Resistant ...
BioSpace
HOUSTON--(BUSINESS WIRE)-- Motif Neurotech, a neurotechnology company developing minimally-invasive bioelectronics for mental health,...
3 months ago
An extended motif in the SARS-CoV-2 spike modulates binding and release of host coatomer in retrograde trafficking ...
Nature
β-Coronaviruses such as SARS-CoV-2 hijack coatomer protein-I (COPI) for spike protein retrograde trafficking to the progeny assembly site in...
26 months ago